Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

Innovation “Crisis” And Health Care Reform: Lilly CEO Urges Change In Focus

  • News

Executive Summary

Lilly CEO John Lechleiter is urging policy makers to focus on the "I word" - Innovation - in the context of the health care reform debate

You may also be interested in...



Lilly's Lechleiter Talks Innovation During Obama's Consultation With CEOs

Lilly's CEO was the sole representative of the biopharmaceutical industry participating in President Obama's meeting with the leaders of 20 large U.S. corporations.

Lilly's Lechleiter Talks Innovation During Obama's Consultation With CEOs

Lilly's CEO was the sole representative of the biopharmaceutical industry participating in President Obama's meeting with the leaders of 20 large U.S. corporations.

Bending The Cost Curve: Obama Presses For Specifics On Coalition Pledge

The White House is expecting a private sector healthcare coalition - including the pharmaceutical industry - to produce details in early June on a pledge to help reduce the annual health care spending growth rate by 1.5 percentage points over the next 10 years

Table

View full table

Topics

Tags:
BioPharmaceutical
UsernamePublicRestriction

Register

PS051070

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By